Csenge Advisory Group’s Pediatrix Medical MD Stock Holding History

Csenge Advisory Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20	Closed	–	–	937
2018 Q3	$0	Buy	+20	New	+$918	﹤0.01%	1363

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Csenge Advisory Group's MD Position: Q4 2018 in Review

Csenge Advisory Group sold out of Pediatrix Medical (MD) in Q4 2018, closing a stake of 20 shares.

Csenge Advisory Group first reported a position in MD in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 307 funds tracked by Wall St. Rank hold MD as of Q4 2018.

Csenge Advisory Group reported no remaining Pediatrix Medical position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 20 Pediatrix Medical shares in Q4 2018.
Csenge Advisory Group first reported a position in Pediatrix Medical in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Pediatrix Medical position peaked at $0 in Q3 2018.
307 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.